WallStSmart

Albemarle Corp (ALB)vsEcolab Inc (ECL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ecolab Inc generates 199% more annual revenue ($16.45B vs $5.49B). ECL leads profitability with a 12.8% profit margin vs -4.2%. ALB appears more attractively valued with a PEG of 1.04. ECL earns a higher WallStSmart Score of 57/100 (C).

ALB

Buy

55

out of 100

Grade: C

Growth: 4.7Profit: 4.0Value: 4.3Quality: 7.5
Piotroski: 4/9Altman Z: 1.78

ECL

Buy

57

out of 100

Grade: C

Growth: 5.3Profit: 7.5Value: 4.3Quality: 5.0
Piotroski: 3/9Altman Z: 2.17
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALBSignificantly Overvalued (-70.0%)

Margin of Safety

-70.0%

Fair Value

$103.22

Current Price

$155.44

$52.22 premium

UndervaluedFair: $103.22Overvalued

Intrinsic value data unavailable for ECL.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALB4 strengths · Avg: 8.8/10
Revenue GrowthGrowth
32.7%10/10

Revenue surging 32.7% year-over-year

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Operating MarginProfitability
24.8%8/10

Strong operational efficiency at 24.8%

ECL2 strengths · Avg: 9.0/10
Market CapQuality
$72.12B9/10

Large-cap with strong market position

Return on EquityProfitability
21.1%9/10

Every $100 of equity generates 21 in profit

Areas to Watch

ALB4 concerns · Avg: 2.3/10
Altman Z-ScoreHealth
1.784/10

Distress zone — elevated risk

Return on EquityProfitability
-2.4%2/10

ROE of -2.4% — below average capital efficiency

EPS GrowthGrowth
-66.2%2/10

Earnings declined 66.2%

Profit MarginProfitability
-4.2%1/10

Currently unprofitable

ECL3 concerns · Avg: 3.7/10
PEG RatioValuation
2.314/10

Expensive relative to growth rate

P/E RatioValuation
34.7x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : ALB

The strongest argument for ALB centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 32.7% demonstrates continued momentum. PEG of 1.04 suggests the stock is reasonably priced for its growth.

Bull Case : ECL

The strongest argument for ECL centers on Market Cap, Return on Equity.

Bear Case : ALB

The primary concerns for ALB are Altman Z-Score, Return on Equity, EPS Growth.

Bear Case : ECL

The primary concerns for ECL are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

ALB profiles as a hypergrowth stock while ECL is a value play — different risk/reward profiles.

ALB carries more volatility with a beta of 1.31 — expect wider price swings.

ALB is growing revenue faster at 32.7% — sustainability is the question.

ALB generates stronger free cash flow (248M), providing more financial flexibility.

Bottom Line

ECL scores higher overall (57/100 vs 55/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Albemarle Corp

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Albemarle Corporation is a fine chemical manufacturing company based in Charlotte, North Carolina.

Ecolab Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Ecolab Inc., headquartered in St. Paul, Minnesota, is an American corporation that develops and offers services, technology and systems that specialize in water treatment, purification, cleaning and hygiene in a wide variety of applications. It helps organizations both private market as well as public treat their water, not only for drinking directly, but also for use in food, healthcare, hospitality related safety and industry.

Want to dig deeper into these stocks?